消化器疾患ベストアンサー　Vol.1

出版社： 医学と看護社
発行日： 2015-05-01
分野： 臨床医学：内科  >  雑誌
雑誌名：
電子書籍版： 2015-05-01 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

4,400 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

目次

  • 消化器疾患ベストアンサー　Vol.1

    ―目次―

    1 章　食道・胃
    CQ1 食道癌術前補助療法後の評価にPET-CT検査は有用か？
    CQ2 食道癌3領域郭清手術において気管虚血の予防策はあるのか？
    CQ3 進行胃癌に対して腹腔鏡下胃切除術を行ってよいか？
    CQ4 膵浸潤が疑われる進行胃癌に対して膵合併切除術をすべきか？
    CQ5 すべての進行胃癌に対して審査腹腔鏡を行うべきか？
    CQ6 審査腹腔鏡の診断精度を上げる新しい胃癌腹膜播種診断法は
    　　　存在するか？
    CQ7 初回手術時に判明した胃癌腹膜播種症例に対して、
    　　　化学療法を施行した後の胃切除術は行うべきか？
    CQ8 超高齢者（80歳以上）の根治切除不能進行胃癌症例に対する
    　　　化学療法は行うべきか？
    CQ9 噴門近傍の胃粘膜下腫瘍に対する腹腔鏡下胃局所切除術
    　　　―狭窄予防のためのテクニックは？

    2 章　大腸
    CQ10 直腸癌低位前方切除術において、術中の切除標本確認にて、
    　　　腸管の肛門側切除距離が短かった場合、追加切除が必要か？
    CQ11 直腸癌局所再発に対してR0手術が可能ならば骨盤内臓全摘術
    　　　まで行うべきか？
    CQ12 直腸癌の超低位前方切除術で一時的回腸人工肛門は全例に
    　　　必要か？
    CQ13 大腸癌治癒切術後にCEAが上昇する症例のfollow upは
    　　　どうすべきか？
    CQ14 下部消化管穿孔手術においてSSI発生予防のために
    　　　皮下ドレーンを留置すべきか？

    3 章　肝胆膵
    CQ15 大腸癌の同時性肝転移における原発巣と肝転移巣の
    　　　同時切除に対して腹腔鏡下手術は安全か？
    CQ16 胆管癌手術において術中迅速病理診断陽性！
    　　　適切な対処法は？
    CQ17 胆道癌の術前診断：PET-CT検査で大動脈周囲リンパ節陽性は
    　　　信用できるか？
    CQ18 原発性十二指腸癌に対して全例に膵頭十二指腸切除術を
    　　　選択すべきか？
    CQ19 膵癌に対する尾側膵切除術を腹腔鏡下に行ってもよいか？
    CQ20 尾側膵切除術後の膵液瘻の危険因子と予防対策はあるか？

    4 章　肥満・ヘルニア・イレウス
    CQ21 肥満外科手術で糖尿病は寛解するか？
    CQ22 機械的イレウス（単純性）に対し、イレウス管による
    　　　減圧療法時に手術に踏み切るタイミングは？
    CQ23 機械的イレウス（単純性）に対する
    　　　ガストログラフィン造影は病態の改善に有用か？
    CQ24 成人鼠径ヘルニアに対する腹腔鏡下手術の選択は
    　　　TEPかTAPPか？

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 食道・胃

P.16 掲載の参考文献
Noguchi T, et al. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma. Dis Esophagus. 2004 ; 17 (1) : 27-31.
PubMed
Fujita H, et al. An experimental study on viability of the devascularized trachea. Jpn J Surg. 1988 Jan ; 18 (1) : 77-83.
 
Nakahara R, et al. Evaluation of tracheal mucosal blood flow during an extended radical operation for esophageal carcinoma : clinical and experimental studies. Surg Today. 1994 ; 24 (7) : 585-90.
PubMed
P.19 掲載の参考文献
1) Memon MA, et al. Meta-analysis of laparoscopic and open distal gastrectomy for gastric carcinoma. Surg Endosc. 2008 ; 22 (8) : 1781-9.
PubMed
2) Eduardo F Vinuela, et al. Laparoscopic versus Open distal gastrectomy for gastric cancer. A Meta-Analysis of RCT and High-Quality Nonrandomized Studies. Ann Surg. 2012 ; 255 (3) : 446-56.
 
3) Qiu J, et al. Laparoscopy versus open distal gastrectomy for advanced gastric cancer : a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2013 ; 23 (1) : 1-7.
PubMed
4) Kitano S, et al. A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer : an interim report. Surgery. 2002 ; 131 (1 Suppl) : S306-11.
 
5) Kim HH, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer : an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010 ; 251 (3) : 417-20.
PubMed
6) Katai H, et al and JCOG Gastric Cancer Surgical Study Group. Safety and feasibility of laparoscopyassisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer : a multicenter phase II trial (JCOG 0703). Gastric Cancer. 2010 ; 13 (4) : 238-44.
 
7) Kitano S, et al and Japanese Laparoscopic Surgery Study Group. A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan. Ann Surg. 2007 ; 245 (1) : 68-72.
 
8) Yasunaga H, et al. Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer : a propensity-matched analysis. Ann Surg. 2013 ; 257 (4) : 640-6.
 
9) Shinohara T, et al. Laparoscopic versus open D2 gastrectomy for advanced gastric cancer : a retrospective cohort study. Surg Endosc. 2013 ; 27 (1) : 286-94.
PubMed
P.23 掲載の参考文献
1) Kasakura Y, et al. Is there a benefit of pancreaticosplenectomy with gastrectomy for advanced gastric cancer? Am J Surg. 2000 Mar ; 179 (3) : 237-42.
 
2) Otsuji E, et al. Total gastrectomy with simultaneous pancreaticosplenectomy or splenectomy in patients with advanced gastric carcinoma. Br J Cancer. 1999 Apr ; 79 (11-12) : 1789-93.
 
3) Kitamura K, et al. No survival benefit from combined pancreaticosplenectomy and total gastrectomy for gastric cancer. Br J Surg. 1999 Jan ; 86 (1) : 119-22.
PubMed
4) Min JS, et al. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type. Ann Surg Oncol. 2012 Feb ; 19 (2) : 494-501.
 
5) Sakamoto Y, et al. Surgical indications for gastrectomy combined with distal or partial pancreatectomy in patients with gastric cancer. World J Surg. 2012 Oct ; 36 (10) : 2412-9.
PubMed
6) Nunobe S, et al. Survival benefits of pancreatoduodenectomy for gastric cancer : relationship to the number of lymph node metastases. Langenbecks Arch Surg. 2008 Mar ; 393 (2) : 157-62.
 
7) Shchepotin IB, et al. Extended surgical resection in T4 gastric cancer. Am J Surg. 1998 ; 175 : 123-6.
PubMed
8) Martin RC II, et al. Extended local resection for advanced gastric cancer : increased survival versus increased morbidity. Ann Surg. 2002 ; 236 : 159-65.
 
9) Kobayashi A, et al. Aggressive surgical treatment for T4 gastric cancer. J Gastrointest Surg. 2004 ; 8 : 464-70.
PubMed
P.27 掲載の参考文献
1) Karanicola S PJ, et al. Staging laparoscopy in the Management of gastric cancer : A population-based analysis. J Am Coll Surg. 2011 ; 213 : 644-51.
 
2) Edmund C, et al. Laparoscopy in the management of gastric adenocarcinoma. Annals of surgery. 1997 ; 225 : 262-7.
 
3) Leake PA, et al. A systematic review of the accuracy and indications for diagnostic laparoscopy prior curative-intent resection of gastric cancer. Gastric cancer. 2012 ; 15 : S38-47.
PubMed
4) Chang L, et al. The role of staging laparoscopy for intraabdominal cancers : an evidence-based review. Endosc. 2009 ; 23 : 231-41.s
 
5) Burbige S, et al. The role of CT and staging laparoscopy in the staging of gastric cancer. Clinical Radiology. 2013 ; 68 : 251-5.
 
6) Muntean V, et al. Staging laparoscopy in gastric cancer : Accuracy and inpact on therapy. J Gastrointestin Liver Dis. 2009 ; 18 : 189-95.
 
7) Tanaka T, et al. Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement ; extranodal invasion is significant risk factor for peritoneal metastasis. J Surg Oncol. 2000 ; 75 : 165-71.
PubMed
8) Tsuchida K, et al. Indication for staging laparoscopy in clinical T4M0 Gastric cancer. World J Surg. 2011 ; 35 : 2703-9.
PubMed
9) Kurita N, et al. Predictive factors of peritoneal metastasis in gastric cancer. Hepatogastroenterology. 2010 ; 57 : 980-3.
PubMed
10) Maehara Y, et al. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metasatasis. Surgery. 1991 ; 110 : 820-3.
PubMed
11) Thomassen l, et al. Peritoneal carcinomatosis of gastric origin : a population-based study on incidence, survival and risk factors. Int J Cancer. 2014 ; 134 : 622-8.
 
P.31 掲載の参考文献
1) Yang QM (静岡がんセンター), et al. 1 The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies. Gan To Kagaku Ryoho. 2006 Nov ; 33 (12) : 1817-21.
 
1) Kishi K (大阪医療センター), et al. Diagnostic Laparoscopy with5-Aminolevulinic-Acid-Mediated Photodynamic Diagnosis Enhances the Detection of Peritoneal Micrometastases in Advanced Gastric Cancer. Oncology. 2014 Aug15 ; 87 (5) : 257-65.
 
2) Namikawa T (高知医大), et al. Photodynamic diagnosis using 5-aminolevulinic acid during gastrectomy for gastric cancer. J Surg Oncol. 2014 Mar ; 109 (3) : 213-7.
 
2) Shinya S (山本記念病院), et al. The usefulness of diffusion-weighted imaging (DWI) for the detection of gastric cancer. Hepatogastroenterology. 2007 Jul-Aug ; 54 (77) : 1378-8117708258.
 
3) Kishi K (大阪医療センター), et al. Staging laparoscopy using ALA-mediated photodynamic diagnosis improves the detection of peritoneal metastases in advanced gastric cancer. J Surg Oncol. 2012 Sep 1 ; 106 (3) : 294-8.
 
3) Muntean V (Railway Clinical Hospital ; ルーマニア), et al. Staging laparoscopy in gastric cancer. Accuracy and impact on therapy. J Gastrointestin Liver Dis. 2009 Jun ; 18 (2) : 189-95.
 
4) Murayama Y (京都府立医大), et al. Staging fluorescence laparoscopy for gastric cancer byusing 5-aminolevulinic acid. Anticancer Res. 2012 Dec ; 32 (12) : 5421-7.
 
5) Fujiwara Y, et al. The clinical importance of a transcription reverse-transcription concerted (TRC) diagnosis using peritoneal lavage fluids in gastric cancer with clinical serosal invasion : a prospective, multicenter study. Surgery. 2014 Mar ; 155 (3) : 417-23.
PubMed
6) Nishizawa M (東京女子医大 2外科), et al. Usefulness of the TRC method in the peritoneal washing cytology for gastric cancer. Hepatogastroenterology. 2014 Jan-Feb ; 61 (129) : 240-4.
 
7) Ishii T (大阪大学), et al. Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis. Ann Surg Oncol. 2004 Aug ; 11 (8) : 778-85.
 
8) Sakakura C (京都府立医大), et al. Overexpression of dopa decarboxylase in peritoneal dissemination of gastric cancer and its potential as a novel marker for the detection of peritoneal micrometastases with real-time RT-PCR. Br J Cancer. 2004 Feb 9 ; 90 (3) : 665-71.
 
9) Mimori K (九州大学別府病院), et al. A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases. Ann Surg Oncol. 2008 Oct ; 15 (10) : 2934-42. doi : 10.1245/s10434-008-9916-z. Epub 2008 Jul 26.
 
P.35 掲載の参考文献
1) Ishigami H, et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010 Jan ; 21 (1) : 67-70.
 
2) Imano M, et al. Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis. J Gastrointest Surg. 2012 Dec ; 16 (12) : 2190-6.
PubMed
3) Fujiwara Y, et al. Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. J Surg Oncol. 2012 Jan ; 105 (1) : 38-42.
 
4) 石神浩徳 他. 胃癌腹膜播種に対する治療戦略. 日外会誌. 2012 ; 113 (1) : 18-21.
 
5) Yonemura Y, et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol. 2006 Aug ; 32 (6) : 661-5.
PubMed
6) Okabe H, et al. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009 Dec ; 16 (12) : 3227-36.
 
7) Fujiwara Y, et al. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Ann Surg Oncol. 2011 Dec ; 18 (13) : 3726-31.
PubMed
8) Yamamoto M, et al. Preliminary trial of surgery after chemotherapy for advanced gastric cancer with peritoneal dissemination. Oncol Lett. 2012 Mar ; 3 (3) : 662-6.
PubMed
9) Kitayama J, et al. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. Ann Surg Oncol. 2014 Feb ; 21 (2) : 539-46.
 
10) Yonemura Y, et al. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer : Selection for cytoreductive surgery. J Surg Oncol. 2009 Sep 15 ; 100 (4) : 311-6.
PubMed
11) Tamura S, et al. Pilot study of a combination of S-1 and paclitaxel for patients with peritoneal metastasis from gastric cancer. Gastric Cancer. 2010 Jun ; 13 (2) : 101-8.
PubMed
P.39 掲載の参考文献
1) J-L Lee, et al. A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer. Br J Cancer. 2008 Aug 19 ; 99 (4) : 584-90.
 
2) Koizumi W, et al. Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer : the Tokyo Cooperative Oncology Group study. Cancer Chemother Pharmacol. 2010 May ; 65 (6) : 1093-9.
 
3) Imamura H, et al. Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404). J Chemother. 2014 Feb ; 26 (1) : 57-61.
PubMed
4) Santini D, et al. Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer : results of a phase II trial. BMC Cancer. 2006 May 10 ; 6 : 1.
PubMed
5) Catalano V, et al. A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases. Gastric Cancer. 2013 Jul ; 16 (3) : 411-9.
 
6) Ikeda N, et al. A phase II study of doxifluridine in elderly patients with advanced gastric cancer : the Japan Clinical Oncology Group Study (JCOG 9410). Jpn J Clin Oncol. 2002 Mar ; 32 (3) : 90-4.
 
7) Graziano F, et al. A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. Br J Cancer. 2003 Oct 20 ; 89 (8) : 1428-32.
PubMed
8) Fonck M, et al. Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer : a first-line phase II study. Clin Res Hepatol Gastroenterol. 2011 Dec ; 35 (12) : 823-30.
PubMed
9) Xiang XJ, et al. A phase II study of capecitabine plus oxaliplatin as first-line chemotherapy in elderly patients with advanced gastric cancer. Chemotherapy. 2012 ; 58 (1) : 1-7.
PubMed
10) Tsushima T, et al. Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer. Gastric Cancer. 2010 Nov ; 13 (4) : 245-50.
PubMed
11) Tsushima T, et al. Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer. Int J Clin Oncol. 2013 Feb ; 18 (1) : 10-6.
PubMed
12) Kunisaki C, et al. Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer. Anticancer Res. 2013 Feb ; 33 (2) : 697-704.
PubMed
13) Liu ZF, et al. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer. Am J Clin Oncol. 2008 Jun ; 31 (3) : 259-63.
PubMed
14) Cho YH, et al. Comparative analysis of the efficacy and safety of chemotherapy with oxaliplatin plus fluorouracil/leucovorin between elderly patients over 65 years and younger patients with advanced gastric cancer. Gastric Cancer. 2012 Oct ; 15 (4) : 389-95.
PubMed
15) Dong N, et al. Triweekly oxaliplatin plus oral capecitabine as first-line chemotherapy in elderly patients with advanced gastric cancer. Am J Clin Oncol. 2009 Dec ; 32 (6) : 559-63.
PubMed
16) Yakabe T, et al. Second-line chemotherapy with paclitaxel and doxifluridine after failure of S-1 in elderly patients with unresectable advanced or recurrent gastric cancer. J Cancer Res Clin Oncol. 2011 Oct ; 137 (10) : 1499-504.
PubMed
P.43 掲載の参考文献
1) Sakamoto Y, et al. Safe laparoscopic resection of a gastric gastrointestinal stromal tumor close to the esophagogastric junction. Surg Today. 2012 Jul ; 42 (7) : 708-11.
 
2) Hiki N, et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc. 2008 Jul ; 22 (7) : 1729-35.
PubMed
3) Mitsui T, et al. Non-exposed endoscopic wall-inversion surgery as a novel partial gastrectomy technique. Gastric Cancer. 2014 Jul ; 17 (3) : 594-9.
 
4) Li QL, et al. Submucosal tumors of the esophagogastric junction originating from the muscularis propria layer : a large study of endoscopic submucosal dissection (with video). Gastrointest Endosc. 2012 Jun ; 75 (6) : 1153-8.
 
5) Mori H, et al. Establishment of the hybrid endoscopic full-thickness resection of gastric gastrointestinal stromal tumors. Mol Clin Oncol. 2015 Jan ; 3 (1) : 18-22.
PubMed

2章 大腸

P.47 掲載の参考文献
1) Vernava, et al. A prospective evaluation of distal margins in carcinoma of the rectum. Surg Gynecol Obstet. 1992 ; 175 (4) : 333-6.
PubMed
2) Shirouzu K, et al. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer. 1995 ; 76 (3) : 388-92.
PubMed
3) Kwok SP, et al. Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma. Br J Surg. 1996 ; 83 (7) : 969-72
 
4) Andreola S, et al. Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosis. Dis Colon Rectum. 1997 ; 40 (1) : 25-9
 
5) Andreola S, et al. Adenocarcinoma of the lower third of the rectum surgically treated with a 10-MM distal clearance : preliminary results in 35 N0 patients. Ann Surg Oncol. 2001 ; 8 (7) : 611-5
PubMed
6) Ono C, et al. Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ. Dis Colon Rectum. 2002 ; 45 (6) : 744-9
 
7) Moore HG, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol. 2003 ; 10 (1) : 80-5.
PubMed
8) Rullier E, et al. Sphincter-saving resection for all rectal carcinomas : the end of the 2-cm distal rule. Ann Surg. 2005 ; 241 (3) : 465-9.
 
9) Mezhir JJ, et al. Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum : what is now the appropriate distal resection margin? Surgery. 2005 ; 138 (4) : 658-63.
PubMed
P.51 掲載の参考文献
1) Yang TX, et al. Pelvic exenteration for rectal cancer : systematic review. Dis Colon Rectum. 2013 ; 56 : 519-31.
PubMed
2) Nielsen MB, et al. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database. Colorectal Dis. 2012 ; 14 : 1076-83.
PubMed
3) Hsu TW, et al. Pelvic exenteration for men with locally advanced rectal cancer : a mobidity analysis of complicated cases. Asian J Surg. 2011 ; 34 : 115-20
 
4) Kecmanovic DM, et al. Management of advanced pelvic cancer by exenteration. Eur J Surg Oncolol. 2003 ; 29 : 743-6.
 
5) Gannon CJ, et al. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol. 2007 ; 14 : 1870-7.
PubMed
6) Domes TS, et al. Total pelvic exenteration for rectal cancer : outcomes and prognostic factors. Can J Surg. 2011 ; 54 (6) : 387-93.
PubMed
7) Ferenschild FT, et al. Total pelvic exenteration for primary and recurrent malignancies. World J Surg. 2009 ; 33 : 1502-8.
PubMed
8) Vermaas M, et al. Total pelvic exenteration for primary locally advanced and locally recurrent rectal cancer. Eur J Surg Oncol. 2007 ; 33 : 452-8
 
9) Kakuda JT, et al. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg. 2003 ; 186 : 660-4.
PubMed
10) Moriya Y, et al. Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum. 2004 ; 47 : 2047-53.
PubMed
11) Fujii S, et al. Surgical strategy for local recurrence after resection of rectal cancer. Hepatogastroenterology. 2009 ; 56 : 667-71.
PubMed
P.55 掲載の参考文献
1) Snijders HS, et al. Meta-analysis of the risk for anastomotic leakage, the postoperative mortality caused by leakage in relation to the overall postoperative mortality. Eur J Surg Oncol. 2012 Nov ; 38 (11) : 1013-9.
 
2) Xiao L, et al. Can transanal tube placement after anterior resection for rectal carcinoma reduce anastomotic leakage rate? A single-institution prospective randomized study. World J Surg. 2011 Jun ; 35 (6) : 1367-77.
 
3) Yamamoto S, et al. Risk factors for anastomotic leakage after laparoscopic surgery for rectal cancer using a stapling technique. Surg Laparosc Endosc Percutan Tech. 2012 Jun ; 22 (3) : 239-43.
PubMed
4) Marusch F, et al. Value of a protective stoma in low anterior resections for rectal cancer. Dis Colon Rectum. 2002 Sep ; 45 (9) : 1164-71.
PubMed
5) Zhu QL, et al. Laparoscopic low anterior resection for rectal carcinoma : complications and management in 132 consecutive patients. World J Gastroenterol. 2010 Sep 28 ; 16 (36) : 4605-10.
 
6) Piecuch J, et al. Mortality and anastomotic leakage after anterior resection for rectal cancer. Hepatogastroenterology. 2012 May ; 59 (115) : 721-3.
PubMed
7) Yang L, et al. Risk assessment on anastomotic leakage after rectal cancer surgery : an analysis of 753 patients. Asian Pac J Cancer Prev. 2013 ; 14 (7) : 4447-53.
PubMed
8) Moran BJ. Predicting the risk and diminishing the consequences of anastomotic leakage after anterior resection for rectal cancer. Acta Chir Iugosl.2010 ; 57 (3) : 47-50.
PubMed
9) Taflampas P, et al. Anastomotic leakage after low anterior resection for rectal cancer : facts, obscurity, and fiction. Surg Today. 2009 ; 39 (3) : 183-8.
PubMed
10) Meade B, et al. Reducing the incidence and managing the consequences of anastomotic leakage after rectal resection. Acta Chir Iugosl. 2004 ; 51 (3) : 19-23.
 
11) Alberts JC, et al. Predicting risk and diminishing the consequences of anastomotic dehiscence following rectal resection. Colorectal Dis. 2003 Sep ; 5 (5) : 478-82.
PubMed
12) Shiomi A, et al. The indications for a diverting stoma in low anterior resection for rectal cancer : a prospective multicentre study of 222 patients from Japanese cancer centers. Colorectal Dis. 2011 Dec ; 13 (12) : 1384-9.
PubMed
13) Seo SI, et al. The Role of Diverting Stoma After an Ultra-low Anterior Resection for Rectal Cancer. Ann Coloproctol. 2013 Apr ; 29 (2) : 66-71.
PubMed
14) Karahasanoglu T, et al. Evaluation of diverting ileostomy in laparoscopic low anterior resection for rectal cancer. Asian J Surg. 2011 Apr ; 34 (2) : 63-8.
PubMed
P.59 掲載の参考文献
1) Figueredo A, et al. Follow-up of patients with curatively resected colorectal cancer : a practice guideline. BMC Cancer. 2003 Oct 6 ; 3 : 26.
PubMed
2) Bruinvels DJ, et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994 Feb ; 219 (2) : 174-82.
PubMed
3) Lu YY, et al. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA : a systematic review and meta-analysis. Int J Colorectal Dis. 2013 Aug ; 28 (8) : 1039-47.
 
4) Primrose JN, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer : the FACS randomized clinical trial. JAMA 2014 Jan 15 ; 311 (3) : 263-70.
PubMed
5) Armitaqe NC, et al. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer. Clin Oncol. 1984 Jun ; 10 (2) : 141-7.
 
6) Litvka A, et al. False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Canc Netw. 2014 Jun ; 12 (6) : 907-13.
PubMed
7) Moertel CG, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993 Aug 25 ; 270 (8) : 943-7.
 
8) Hara M, et al. Does serum carcinoembryonic antigen elevation in patients with postoperative stage II colorectal cancer indicate recurrence? Comparison with stage III. J Surg Oncol. 2010 Aug 1 ; 102 (2) : 154-7.
 
9) Accuracy of monitoring serum carcinoembryonic antigen levels in postoperative stage III colorectal cancer patients is limited to only the first postoperative year. Surg Today. 2011 Oct ; 41 (10) : 1357-62.
PubMed
10) Kyoto Y, et al. Ability of 18F.-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. Ann Nucl Med. 2010 Jun ; 24 (5) : 395-401.
PubMed
P.63 掲載の参考文献
1) Numata M, et al. A prospective randomized controlled trial of subcutaneous passive drainage for the prevention of superficial surgical site infections in open and laparoscopic colorectal surgery. Int J Colorectal Dis. 2014 Mar ; 29 (3) : 353-8.
PubMed
2) Murakami M, et al. Subcutaneous Drains Prevent Incisional Surgical Site Infection in Panperitonitis Surgery. J Abdom Emerg Med. 2013 Dec ; 33 (8) : 1237-43.
 
3) Imada S, et al. Efficacy of subcutaneous drains for surgical site infections in colorectal surgery. World J Gastrointest Surg. 2013 Apr 27 ; 5 (4) : 110-4.
 
4) Fujii T, et al. Effects of subcutaneous drain for the prevention of incisional surgical site infection in high-risk patients undergoing colorectal surgery. Int J Colorectal Dis. 2011 Sep ; 26 (9) : 1151-5.
PubMed
5) Naruse T, et al. The efficacy of subcutaneous drains for the prevention of superficial surgical site infections in surgery patients with gastrointestinal perforation. J Abdom Emerg Med. 2012 Sep ; 32 (6) :1057-60.
 
6) Shindo Y, et al. Efficacy of subcutaneous continuous aspiration drainage for the prevention of superficial surgical-site infection in patients with gastrointestinal perforation. J Abdom Emerg Med. 2010 Dec ; 30 (7) : 889-92.
 

3章 肝胆膵

P.67 掲載の参考文献
1) Mentha G, et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumor. Eur J Surg Oncol. 2007 ; 33 Suppl 2 : S76-83.
 
2) Hillingso JG, et al. Staged or simultaneous resection of synchronous liver metastases from colorectal cancer-a systematic review. Colorectal Dis. 2009 ; 11 (1) : 3-10.
 
3) Turrini O, et al. Strategies for the treatment of synchronous liver metastasis. Eur J Surg Oncol. 2007 ; 33 (6) : 735-40. Epub 2007 Apr 2.
 
4) Weber JC, et al. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg. 2003 ; 90 (8) : 956-62.
PubMed
5) Lyass S, et al. Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol. 2001 ; 78 (1) : 17-21.
PubMed
6) Martin RC, et al. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases. J Am Coll Surg. 2009 ; 208 (5) : 842-50
 
7) Martin R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003 ; 197 (2) : 233-41.
PubMed
8) Tanaka K, et al. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004 ; 136 (3) : 650-9.
PubMed
9) Chua HK, et al. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum. 2004 ; 47 (8) : 1310-6.
PubMed
10) Brouquet A, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients : classic, combined or reverse strategy? J Am Coll Surg. 2010 ; 210 (6) : 934-41.
PubMed
11) Lupinacci RM, et al. Simultaneous laparoscopic resection of primary colorectal cancer and associated liver metastases : a systematic review. Tech Coloproctol. 2014 ; 18 (2) : 129-35.
PubMed
12) Hatwell C, et al. Laparoscopic resection of colorectal cancer facilitates simultaneous surgery of synchronous liver metastases. Colorectal Dis. 2013 ; 15 (1) : e21-8.
PubMed
13) Huh JW, et al. Comparison of laparoscopic and open colorectal resections for patients undergoing simultaneous R0 resection for liver metastases. Surg Endosc. 2011 ; 25 (1) : 193-8.
PubMed
14) Polignano FM, et al. Totally laparoscopic strategies for the management of colorectal cancer with synchronous liver metastasis. Surg Endosc. 2012 ; 26 (9) : 2571-8.
PubMed
15) Spampinato MG, et al. One-stage, totally laparoscopic major hepatectomy and colectomy for colorectal neoplasm with synchronous liver metastasis : safety, feasibility and short-term outcome. Surgery. 2013 ; 153 (6) : 861-5.
PubMed
16) Hu MG, et al. Outcomes of open versus laparoscopic procedure for synchronous radical resection of liver metastatic colorectal cancer : a comparative study. Surg Laparosc Endosc Percutan Tech. 2012 ; 22 (4) : 364-9.
PubMed
P.71 掲載の参考文献
1) Wakai, et al. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma. Cancer. 2005 Mar 15 ; 103 (6) : 1210-6.
 
2) Sasaki, et al. Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg. 2007 Sep ; 31 (9) : 1788-96.
PubMed
3) Nakanishi, et al. Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. J Hepatobiliary Pancreat Sci. 2010 Mar ; 17 (2) : 166-73.
PubMed
4) Farges, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma : a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011 Nov ; 254 (5) : 824-29.
 
5) Igami, et al. Clinicopathologic study of cholangiocarcinoma with superficial spread. Ann Surg. 2009 Feb ; 249 (2) : 296-302.
PubMed
6) Konishi, et al. Clinical impact of intraoperative histological examination of the ductal resection margin in extrahepatic cholangiocarcinoma. Br J Surg. 2010 Sep ; 97 (9) : 1363-8.
PubMed
7) Shingu, et al. Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma. Surgery. 2010 Jan ; 147 (1) : 49-56.
PubMed
P.75 掲載の参考文献
1) Kim JY, et al. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma : a prospective study compared with conventional imaging. Am J Gastroenterol. 2008 May ; 103 (5) : 1145-51.
PubMed
2) Furukawa H, et al. Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET : prospective comparison with PET+CT, MDCT and histopathology. Eur Radiol. 2008 Dec ; 18 (12) : 2841-7.
PubMed
3) Lee SW, et al. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol. 2010 May ; 45 (5) : 560-6.
PubMed
4) Ruys AT, et al. FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma. HPB (Oxford). 2011 Apr ; 13 (4) : 256-62.
PubMed
5) Kato T, et al. Clinical role of (18) F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging. 2002 Aug ; 29 (8) : 1047-54.
PubMed
6) Seo S, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery. 2008 Jun ; 143 (6) : 769-77.
PubMed
P.79 掲載の参考文献
1) Solej M, et al. Primary duodenal adenocarcinoma. Tumori. 2008 Nov-Dec ; 94 (6) : 779-86.
 
2) Ohigashi H, et al. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreatoduodenctomy plus extended lymphadenectomy. Surgery. 1998 Sep ; 124 (3) : 510-5.
 
3) Ryder NM, et al. Primary Dudenal adenocarcinoma : a 40-year experience. Arch Surg. 2000 Sep ; 135 (9) : 1070-5.
 
4) Hung FC, et al. Clinical analysis of primary duodenal adenocarcinoma : an 11-year experience. J Gastroenterol Hepatol. 2007 May ; 22 (5) : 724-8.
PubMed
5) Cecchni S, et al. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma. J Gastrointestinal Surg. 2012 Jan ; 16 (1) : 113-20.
 
6) Pickleman J, et al. Node-positive duodenal cancer is curable. Arch Surg. 1997 Mar : 132 (3) : 241-4.
PubMed
7) Kaklamanos IG, et al. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg. 2000 Jan ; 179 (1) : 37-41.
PubMed
8) Bakaeen FG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg. 2000 Jun ; 135 (6) : 635-41.
PubMed
9) Tocchi AT, et al. Adenocarcinoma of the third and fourth portions of duodenum : results of surgical treatment. Arch Surg. 2003 Jan ; 138 (1) : 80-5.
PubMed
10) Han SL, et al. The surgical treatment and outcome for primary duodenal adenocarcinoma. J Gastrointest Canc. 2010 Dec ; 41 (4) : 243-7.
 
11) 尾上俊介 他. 原発性十二指腸癌自験例10例の検討. 日消外. 2006 ; 39 (8) : 1458-63.
 
12) 猪瀬悟史 他. 原発性十二指腸癌27切除例の臨床病理学的検討. 日消外. 2010 ; 43 (2) : 135-40.
 
13) 坂本英至 他. 原発性十二指腸癌切除6例の検討. 日臨外. 2002 ; 63 (1) : 94-8.
 
P.83 掲載の参考文献
1) Xie K, et al. Laparoscopic distal pancreatectomy is as safe and feasible as open procedure : a metaanalysis. World J Gastroenterol. 2012 Apr ; 18 (16) : 1959-67.
PubMed
2) Jin T, et al. A systematic review and meta-analysis of studies comparing laparoscopic and open distal pancreatectomy. HPB. 2012 Nov ; 14 (11) : 711-24.
 
3) Bjornsson B, et al. Laproscopic distal pancreatectomy for adenocarcinoma of the pancreas. World J Gastroenterol. 2014 Oct : 20 (37) : 13402-11.
 
4) Kooby DA, et al. Left-sided Pancreatectomy : a multicenter comparison of laparoscopic and open approaches. Ann Surg. 2008 Sep ; 248 (3) : 438-46.
PubMed
5) Baker MS, et al. A prospective single institution comparison of peri-operative outcomes for laparoscopic and open distal pancreatectomy. Surgery. 2009 Oct ; 146 (4) : 635-43.
PubMed
6) Vijan SS, et al. Laparoscopic vs open distal pancreatectomy : a single-institution comparative study. Arch Surg. 2010 Jul ; 145 (7) : 616-21.
PubMed
7) Jayaraman S, et al. Laparoscopic distal pancreatectomy : evolution of a technique at a single institution. J Am Coll Surg. 2010 Oct ; 211 (4) : 503-9.
 
8) Ammori BJ, et al. Laparoscopic pancreaticoduodenectomy and distal pancreatectomy : a UK experience and a systematic review of the literature. Surg Endosc. 2011 Jul ; 25 (7) : 2084-99.
 
9) Stauffer JA, et al. Comparison of open with laparoscopic distal pancreatectomy : a single institution's transition over a 7-year period. HPB. 2013 Feb ; 15 (2) : 149-55.
 
10) Kooby DA, et al. A multicenter analysis of distal pancreatectomy for adenocarcinoma : Is laparoscopic resection appropriate? J Am Coll Surg. 2010 May ; 210 (5) : 779-87.
PubMed
11) Marangos IP, et al. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival. Surgery. 2012 May ; 151 (5) : 717-23.
 
P.87 掲載の参考文献
1) Ban D, et al. Stapler and nonstapler closure of the pancreatic remnant after distal pancreatectomy : multicenter retrospective analysis of 388 patients. World J Surg. 2012 Aug ; 36 (8) : 1866-73.
PubMed
2) Kleeff J, et al. Distal pancreatectomy : risk factors for surgical failure in 302 consecutive cases. Ann Surg. 2007 Apr ; 245 (4) : 573-82.
PubMed
3) Hashimoto Y, et al. After distal pancreatectomy pancreatic leakage from the stump of the pancreas may be due to drain failure or pancreatic ductal back pressure. J Gastrointest Surg. 2012 May ; 16 (5) : 993-1003.
PubMed
4) Kawai M, et al. Stump closure of a thick pancreas using stapler closure increases pancreatic fistula after distal pancreatectomy. Am J Surg. 2013 Sep ; 206 (3) : 352-9.
PubMed
5) Seeliger H, et al. Risk factors for surgical complications in distal pancreatectomy. Am J Surg. 2010 Sep ; 200 (3) : 311-7.
PubMed
6) Zhou W, et al. Stapler vs suture closure of pancreatic remnant after distal pancreatectomy : a meta-analysis. Am J Surg. 2010 Oct ; 200 (4) : 529-36.
PubMed
7) Koti RS, et al. Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery : a Cochrane review. HPB (Oxford). 2010 Apr ; 12 (3) : 155-65.
PubMed
8) Frozanpor F, et al. The effect of prophylactic transpapillary pancreatic stent insertion on clinically significant leak rate following distal pancreatectomy : results of a prospective controlled clinical trial. Ann Surg. 2012 Jun ; 255 (6) : 1032-6.
PubMed
9) Carter TI, et al. A dual-institution randomized controlled trial of remnant closure after distal pancreatectomy : does the addition of a falciform patch and fibrin glue improve outcomes? J Gastrointest Surg. 2013 Jan ; 17 (1) : 102-9.
PubMed
10) Bassi C, et al. Early versus late drain removal after standard pancreatic resections : results of a prospective randomized trial. Ann Surg. 2010 Aug ; 252 (2) : 207-14.
PubMed

4章 肥満・ヘルニア・イレウス

P.91 掲載の参考文献
1) Gloy VL, et al. Bariatric surgery versus non-surgical treatment for obesity : a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013 Oct 22 ; 347 : f5934.
PubMed
2) Li JF, et al. Comparison of laparoscopic Roux-en-Y gastric bypass with laparoscopic sleeve gastrectomy for morbid obesity or type 2 diabetes mellitus : a meta-analysis of randomized controlled trials. Can J Surg. 2013 Dec ; 56 (6) : E158-64.
PubMed
3) Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes. N Engl J Med. 2014 May 22 ; 370 (21) : 2002-13.
 
4) Lee WJ, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus : 5-year results of a randomized trial and study of incretin effect. Obes Surg. 2014 Sep ; 24 (9) : 1552-62.
PubMed
5) Lee WJ, et al. Predicting success of metabolic surgery : age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013 May-Jun ; 9 (3) : 379-84.
 
6) Dixon JB, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care. 2013 Jan ; 36 (1) : 20-6.
PubMed
7) Lee W, et al. Metabolic surgery ABCD score : predicting the success of surgical treatment diabetes. Obes Surg. 2013 Aug ; 23 (8) : 1020.
 
P.95 掲載の参考文献
1) Tanaka S, et al. Predictive factors for surgical indication in adhesive small bowel obstruction. Am J Surg. 2008 Jul ; 196 (1) : 23-7. Osaka City University Graduate School of Medicine, Osaka, Japan.
 
2) Sakakibara T, et al. The indicator for surgery in adhesive small bowel obstruction patient managed with long tube. Hepatogastroenterology. 2007 Apr-May ; 54 (75) : 787-90. Nagoya University Graduate School of Medicine, Japan.
PubMed
3) 榊原巧 (名古屋大学 大学院病態制御外科学) 他. イレウス管による術後癒着性イレウス保存的改善後の再発関連因子の検討. 日本腹部救急医学会雑誌. 2007 ; 27 (1) : 13-7.
 
4) 川崎誠康他. 小腸イレウスの診断と手術適応基準の検討. 日本臨床外科学会雑誌. 2007 ; 68 (6) : 1369-76.
 
5) 榊原巧 (名古屋大学 大学院病態制御外科学) 他. 高齢者の術後癒着性イレウスにおけるイレウス管留置の功罪. 日本臨床外科学会雑誌. 2006 ; 67 (8) : 1733-8.
 
6) 村上真 (福井医科大学 第1外科) 他. 機械的イレウスの治療法選択とそのタイミング. 北陸外科学会雑誌. 2003 ; 22 (1) : 15-9.
 
7) 吉田孝太郎 (東京女子医科大学 2外) 他. イレウスの手術時期決定と術式の選択. 外科治療. 2002 ; 86 (6) : 1136-40.
 
8) 村上雅彦 (昭和大学 医 第2外科) 他. 術後癒着性イレウスの治療. 救急医学. 2000 ; 24 (7) : 796-9.
 
P.99 掲載の参考文献
1) Fleshner PR, et al. A prospective randomized trial of short versus long tubes in adhesive small bowel obstruction. Am J Surg. 1995 ; 170 : 366-9. Mount Sinai Hospital, USA.
 
2) Chen XL, et al. A prospective randomized trial of trans nasal ileus tube vs. nasogastric tube for adhesive small bowel obstruction. World J Gastroenterol. 2012 Apr 28 ; 18 (16) : 1968-74. Zhejiang University, China.
 
3) Gowen GF. Long tube decompression is successful in 90% of patients with adhesive small bowel obstruction. Am J Surg. 2003 Jun ; 185 (6) : 512-5. Thomas Jefferson University, USA.
 
4) Abbas SM, et al. Meta-analysis of oral water-soluble contrast agent in the management of adhesive small bowel obstruction. Br J Surg. 2007 Apr ; 94 (4) : 404-11. University of Bologna, Italy.
 
5) Branco BC, et al. Systematic review and meta-analysis of the diagnostic and therapeutic role of watersoluble contrast agent in adhesive small bowel obstruction. Br J Surg. 2010 University of Southern California, USA.
PubMed
6) Farid M, et al. Clinical impacts of oral gastrografin follow-through in adhesive small bowel obstruction (SBO). J Surg Res. 2010 Aug ; 162 (2) : 170-6.
PubMed
7) Choi HK, et al. Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment : a prospective randomized trial. Ann Surg. 2002 Jul ; 236 (1) : 1-6.
PubMed
P.103 掲載の参考文献
1) O'Reilly EA, et al. A meta-analysis of surgical morbidity and recurrence after laparoscopic and open repair of primary unilateral inguinal hernia. Ann Surg. 2012 May ; 255 (5) : 846-53.
PubMed
2) Bracale U, et al. Which is the best laparoscopic approach for inguinal hernia repair : TEP or TAPP? A systematic review of the literature with a network meta-analysis. Surg Endosc. 2012 Dec ; 26 (12) : 3355-66.
PubMed
3) Yang J, et al. Laparoscopic or Lichtenstein repair for recurrent inguinal hernia : a meta-analysis of randomized controlled trials. ANZ J Surg. 2013 May ; 83 (5) : 312-8.
 
4) Antoniou SA, et al. Transabdominal preperitoneal versus totally extraperitoneal repair of inguinal hernia : a meta-analysis of randomized studies. Am J Surg. 2013 Aug ; 206 (2) : 245-52.
PubMed
5) Butler RE, et al. The economic impact of laparoscopic inguinal hernia repair : results of a doubleblinded, prospective, randomized trial. Surg Endosc. 2007 Mar ; 21 (3) : 387-90.
PubMed
6) Hamza Y, et al. Four-arm randomized trial comparing laparoscopic and open hernia repairs. Int J Surg. 2010 ; 8 (1) : 25-8.
PubMed
7) Gong K, et al. Comparison of the open tension-free mesh-plug, transabdominal preperitoneal (TAPP), and totally extraperitoneal (TEP) laparoscopic techniques for primary unilateral inguinal hernia repair : a prospective randomized controlled trial. Surg Endosc. 2011 Jan ; 25 (1) : 234-9.
PubMed
8) Mesci A, et al. Digital evaluation of the muscle functions of the lower extremities among inguinal hernia patients treated using three different surgical techniques : a prospective randomized study. Surg Today. 2012 Jan ; 42 (2) : 157-63.
PubMed
9) Krishna A, et al. Laparoscopic inguinal hernia repair : transabdominal preperitoneal (TAPP) versus totally extraperitoneal (TEP) approach : a prospective randomized controlled trial. Surg Endosc. 2012 Mar ; 26 (3) : 639-49.
PubMed
10) Abbas AE, et al. Patient-perspective quality of life after laparoscopic and open hernia repair : a controlled randomized trial. Surg Endosc. 2012 Sep ; 26 (9) : 2465-70.
PubMed
11) Bignell M, et al. Prospective randomized trial of laparoscopic (transabdominal preperitoneal-TAPP) versus open (mesh) repair for bilateral and recurrent inguinal hernia : incidence of chronic groin pain and impact on quality of life : results of 10 year follow-up. Hernia. 2012 Dec ; 16 (6) : 635-40.
PubMed
12) Wang WJ, et al. Comparison of the effects of laparoscopic hernia repair and Lichtenstein tension-free hernia repair. J Laparoendosc Adv Surg Tech A. 2013 Apr ; 23 (4) : 301-5.
PubMed
13) Tolver MA, et al. Early pain after laparoscopic inguinal hernia repair. A qualitative systematic review. Acta Anaesthesiol Scand. 2012 May ; 56 (5) : 549-57.
PubMed
14) Zanghi A, et al. Multicentric evaluation by Verbal Rate Scale and EuroQoL-5D of early and late postoperative pain after TAPP and TEP procedures with mechanical fixation for bilateral inguinal hernias. Ann Ital Chir. 2011 Nov-Dec ; 82 (6) : 437-42.
 
15) Gass M, et al. TAPP or TEP? Population-based analysis of prospective data on 4,552 patients undergoing endoscopic inguinal hernia repair. World J Surg. 2012 Dec ; 36 (12) : 2782-6.
 
16) Thill V, et al. Long-term results of a non-ramdomized prospective mono-centre study of 1000 laparoscopic totally extraperitoneal hernia repairs. Acta Chir Belg. 2008 Jul-Aug ; 108 (4) : 405-8.
 
17) Simons MP, et al. European Hernia Society guidelines on the treatment of inguinal hernia in adult patients. Hernia. 2009 Aug ; 13 (4) : 343-403.
PubMed
18) Bittner R, et al. Guidelines for laparoscopic (TAPP) and endoscopic (TEP) treatment of inguinal hernia [International Endohernia Society (IEHS)]. Surg Endosc. 2011 Sep ; 25 (9) : 2773-843.
PubMed

書評

最近チェックした商品履歴

Loading...